Steven Kan (阚子义)

Steven Kan has extensive work experience in the biopharmaceutical industry, with a focus on analytical development and quality control. Steven is currently the CTO at Genor BioPharma Co., Ltd., a company that specializes in developing and commercializing oncology and autoimmune antibody drugs. Prior to this, Steven worked as the VP of Quality Control at Livzon and as an Associate Director at Ionis Pharmaceuticals, Inc. In these roles, they oversaw the development, validation/qualification, and implementation of analytical standards and methods. Steven also has experience as a Group Leader/Senior Scientist at Allergan, Senior Principal Scientist at Pfizer, and Senior Scientist at Monsanto Company. Steven began their career as the Mass Spectrometry Facility Manager at Indiana University Bloomington.

Steven Kan (阚子义) completed their education in a chronological order as follows:

- Steven pursued their Bachelor's and Master's degrees in Chemistry at Jilin University.

- Steven obtained their Ph.D. in Analytical Chemistry from The University of British Columbia between 1988 and 1993.

- From 1994 to 1996, they attended Purdue University for a Postdoctoral position, specializing in Fourier Transform Mass Spectrometry.